High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Circulation

• Publication date

  1986-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.74.6.1217PMID 3536151
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men.

  1986cited by this paper
• Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the Multiple Risk Factor Intervention Trial.

  1986cited by this paper
• Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia.

  1986cited by this paper
• High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men.

  1986cited by this paper
• High density lipoprotein metabolism.

  1984cited by this paper
• HDL serum cholesterol and 24-year mortality of men in Finland.

  1984cited by this paper
• The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.

  1984cited by this paper
• Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.

  1984cited by this paper
• Habitual Physical Activity and High‐density Lipoprotein Cholesterol in Men with Primary Hypercholesterolemia: The Lipid Research Clinics Coronary Primary Prevention Trial

  1982cited by this paper
• The Epidemiology of Plasma High‐density Lipoprotein Cholesterol Levels: The Lipid Research Clinics Program Prevalence Study Summary

  1980cited by this paper
• The coronary primary prevention trial: design and implementation: the Lipid Research Clinics Program.

  1979cited by this paper
• High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study.

  1979cited by this paper
• High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study.

  1979cited by this paper
• Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling project research group.

  1978cited by this paper
• High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

  1977cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• Probability of Middle‐Aged Men Developing Coronary Heart Disease in Five Years

  1972cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Estado metabólico y su relación con el consumo máximo de oxígeno en diabéticos tipo 2, corredores y sedentarios sanos.

  2026influential citation
• Oxidized low-density lipoproteins and their contribution to atherosclerosis

  2024cites this paper
• Bioactivities and Applications of Fruit Byproducts and Their Phytochemicals: A Mini Review

  2024cites this paper
• Effect of unripe fruit extract of Momordica charantia on total cholesterol, total triglyceride and blood lipoproteins in the blood of rats with hyperlipidemia

  2022cites this paper
• Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages

  2022cites this paper
• Short-Term Intake of Yellowstripe Scad versus Salmon Did Not Induce Similar Effects on Lipid Profile and Inflammatory Markers among Healthy Overweight Adults despite Their Comparable EPA+DHA Content

  2021cites this paper
• Lower High-Density Lipoprotein Cholesterol Concentration Is Independently Associated with Greater Future Accumulation of Intra-Abdominal Fat

  2021cites this paper
• 7Intracoronary monocyte expression pattern and HDL subfractions after non-ST elevation myocardial infarction.

  2021cites this paper
• High density lipoprotein in atherosclerosis and coronary heart disease: Where do we stand today?

  2021cites this paper
• Anthocyanin supplementation at different doses improves cholesterol efflux capacity in subjects with dyslipidemia—a randomized controlled trial

  2020cites this paper
• Short-term lifestyle intervention program through daily walking improves circulatory low HDL level in rural Bangladeshi women

  2020cites this paper
• Effect of Anacetrapib on Cholesterol Efflux Capacity: A Substudy of the DEFINE Trial

  2020cites this paper
• NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists

  2020cites this paper
• NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists

  2020cites this paper
• Cardioprotective Properties Of Hdl: Structural And Functional Considerations.

  2019cites this paper
• The consumption of 12 Eggs per week for 1 year does not alter fasting serum markers of cardiovascular disease in older adults with early macular degeneration

  2019cites this paper
• HDL cholesterol and ASCVD risk stratification: A debate.

  2019cites this paper
• Effect of Fermented Pentaclethra Macrophylla Benth (African Oil Bean) Seed Extract on Plasma Lipid Profile in Healthy Rat Model-A Preliminary Study

  2019cites this paper
• Effect of Community Exercise for Patients with Stroke: A Systematic Review and Meta-analysis

  2019cites this paper
• Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis

  2018cites this paper
• Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease

  2018influential citation
• The role of sphingosine 1 phosphate in coronary artery disease and ischemia reperfusion injury

  2018cites this paper
• The role of lipoproteins on selected functions relevant to Alzheimer's Disease in human brain perivascular cells

  2018cites this paper
• Low HDL cholesterol and particle concentrations are associated with greater levels of endothelial activation markers in Multi-Ethnic Study of Atherosclerosis participants

  2017cites this paper
• Lysosomal oxidation of Low Density Lipoproteins

  2017cites this paper
• 1 Cardiovascular Risk Investigation : When Should It Start ?

  2017cites this paper
• Low high-density lipoprotein cholesterol and particle concentrations are associated with greater levels of endothelial activation markers in Multi-Ethnic Study of Atherosclerosis participants.

  2017cites this paper
• Oral Apolipoprotein A‐I Mimetic D‐4F Lowers HDL‐Inflammatory Index in High‐Risk Patients: A First‐in‐Human Multiple‐Dose, Randomized Controlled Trial

  2017cites this paper
• High-Density Lipoproteins: Biology, Epidemiology, and Clinical Management.

  2017cites this paper
• Efecto de las resinas secuestradoras de ácidos biliares en los desenlaces cardiovasculares y en los niveles séricos de lípidos

  2016cites this paper
• Is high high-density lipoprotein cholesterol beneficial for premature coronary heart disease? A meta-analysis

  2016cites this paper
• A personalized, multi-platform nutrition, exercise, and lifestyle coaching program: A pilot in women

  2016influential citation
• The ApoM/S1P-complex: its role in vascular inflammatory disease and interaction with S1P-receptors

  2016cites this paper
• Lipoproteins as modulators of atherothrombosis: From endothelial function to primary and secondary coagulation.

  2016cites this paper
• Relationship between aerobic capacity and cardiovascular disease risk factors in Thai men and women with normolipidemia and dyslipidemia

  2015cites this paper
• Alternativas terapéuticas al manejo farmacológico con estatinas en adultos con dislipidemia. Revisión sistemática de la literatura y recomendaciones generales

  2015cites this paper
• MicroRNAs Determining Inflammation as Novel Biomarkers and Potential Therapeutic Targets.

  2015cites this paper
• The role of the lymphatic system in cholesterol transport

  2015influential citation
• RESPONSE OF EXERCISE TRAINING ON HIGH DENSITY LIPOPROTEIN-CHOLESTEROL AND ITS SUBFRACTIONS

  2015cites this paper
• Effects of Community Exercise Therapy on Metabolic, Brain, Physical, and Cognitive Function Following Stroke

  2015cites this paper
• Mitochondrial function and regulation of macrophage sterol metabolism and inflammatory responses.

  2015cites this paper
• A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice.

  2014cites this paper
• ATP Synthase β-Chain Overexpression in SR-BI Knockout Mice Increases HDL Uptake and Reduces Plasma HDL Level

  2014cites this paper
• Anthocyanin supplementation improves HDL-associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia.

  2014cites this paper
• Treatment of dyslipidemia

  2014cites this paper
• Steroidogenic Acute Regulatory Protein (StAR) and Atherogenesis

  2014cites this paper
• Effect of Hippocratea africana Root Bark Extract on Lipid Profile of Female and Male Albino Wistar Rats

  2014cites this paper
• High density lipoprotein structure, function, and metabolism: a new Thematic Series

  2013cites this paper
• Effekten av en inneliggende intensiv livsstilsintervensjon, med stor mengde fysisk aktivitet på risikofaktorer for hjerte-karsykdom hos personer med sykelig overvekt

  2013cites this paper
• High-density lipoproteins: a consensus statement from the National Lipid Association.

  2013cites this paper
• Reconstituted HDL Elicits Marked Changes in Plasma Lipids Following Single-Dose Injection in C57Bl/6 Mice

  2012cites this paper
• Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study.

  2012cites this paper
• High-density lipoprotein subclasses and their relationship to cardiovascular disease.

  2012cites this paper
• HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures

  2012cites this paper
• Transgenic Rabbit Models for Atherosclerosis

  2012cites this paper
• Nutritional genomics for the characterization of the effect of bioactive molecules in lipid metabolism and related pathways

  2012cites this paper
• Cardiovascular Risk Investigation: When Should It Start?

  2012cites this paper
• Transgenic rabbit models for studying human cardiovascular diseases.

  2012cites this paper
• Therapeutic strategies to deplete macrophages in atherosclerotic plaques.

  2012cites this paper
• High-Density Lipoprotein and Mortality Before Age 90 in Male Physicians

  2012cites this paper
• Differential regulation of human apolipoprotein AI and high-density lipoprotein by fenofibrate in hapoAI and hapoAI-CIII-AIV transgenic mice.

  2011cites this paper
• Rheumatoid arthritis: biologicals and bone

  2011cites this paper
• The Role of High-Density Lipoprotein Cholesterol in the Development of Atherosclerotic Cardiovascular Disease

  2011cites this paper
• Efecto de glucosa en la expresión de lipasa endotelial en células endoteliales humanas y en sujetos con diabetes mellitus tipo 2

  2011cites this paper
• The Lipid Research Clinics Coronary Primary Prevention Trial: design, results, and implications

  2011cites this paper
• High-density lipoproteins: a novel therapeutic target for cardiovascular disease

  2011cites this paper
• Apolipoprotein ε4 polymorphism does not modify the association between body mass index and high-density lipoprotein cholesterol: a cross-sectional cohort study

  2011cites this paper
• Apolipoprotein A-I therapy promise, challenges, and disappointment.

  2011cites this paper
• Atherosclerosis induced by arsenic in drinking water in rats through altering lipid metabolism.

  2011cites this paper
• [Glucose effect in the expression of endothelial lipase in human endothelial cells and in patients with diabetes mellitus type 2].

  2011cites this paper
• Postępowanie z chorym po zawale serca

  2011cites this paper
• Impact on Dyslipidemia of the Laparoscopic Ileal Interposition Associated to Sleeve Gastrectomy in Type 2 Diabetic Patients

  2010cites this paper
• Guias de practicas de laboratorio clinico Biomarcadores emergentes para la prevencion primaria de la enfermedad cardiovascular y del accidente cerebrovascular Capitulos 7 al 10

  2010cites this paper
• Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis.

  2010cites this paper
• Les dyslipidémies héréditaires

  2010cites this paper
• Effect of Light and Heavy Smoking on High Density Lipoprotein Cholesterol Level

  2010cites this paper
• South Asians and risk of cardiovascular disease: current insights and trends.

  2010cites this paper
• High-density lipoprotein at the interface of type 2 diabetes mellitus and cardiovascular disorders.

  2010cites this paper
• HDL-cholestérol et risque cardiovasculaire : au-delà du LDL !

  2010cites this paper
• CHAPTER 37 – Special Patient Populations: Diabetes and Metabolic Syndrome

  2009cites this paper
• Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II

  2009cites this paper
• Place des fibrates dans le traitement de patients avec une dyslipidemie atherogene.

  2009cites this paper
• Lipid profile changes associated with changing available formulary statins: removing higher potency agents.

  2009cites this paper
• Cardiovascular event risk: high-density lipoprotein and paraoxonase.

  2009cites this paper
• The Utility of Physical Activity in the Management of Global Cardiometabolic Risk

  2009cites this paper
• Novel therapies for increasing serum levels of HDL.

  2009cites this paper
• CHAPTER 32 – Evolving Targets of Therapy

  2009cites this paper
• New recommendations for the diagnosis and treatment of plasma lipid abnormalities.

  2009cites this paper
• NHG-Standaard Cardiovasculair risicomanagement

  2009cites this paper
• Novel Peroxisome Proliferator-Activated Receptor α Agonists Lower Low-Density Lipoprotein and Triglycerides, Raise High-Density Lipoprotein, and Synergistically Increase Cholesterol Excretion with a Liver X Receptor Agonist

  2008cites this paper
• Free Fatty Acid Metabolism in Visceral Obesity

  2008cites this paper
• Impact of diet, exercise end diet combined with exercise programs on plasma lipoprotein and adiponectin levels in obese girls.

  2008cites this paper
• Belgian expert opinion: how to reduce the residual risk in atherogenic dyslipidaemic patients: place of fibrates

  2008cites this paper
• Impaired Aerobic Capacity in Thai Dyslipidemias

  2008cites this paper
• Physical Activity in the Management of Visceral Obesity and Related Cardiometabolic Risk

  2008cites this paper
• Evaluation of reproductive safety of beta-sitosterol on the American mink (Neovison vison).

  2008cites this paper
• The Association of Plasma HDL-Cholesterol Level with Cardiovascular Disease Related Factors in Korean Type 2 Diabetic Patients

  2008cites this paper
• synergistically increase cholesterol excretion with an LXR agonist.

  2008cites this paper
• Change in high-density lipoprotein cholesterol and incident coronary heart disease in apparently healthy male physicians.

  2008cites this paper
• Renal insufficiency, mortality and myocardial infarction

  2008cites this paper